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Objective: Bemotrizinol (BEMT) is the most efficient broad-spectrum UV-absorber having a dual mechanism of action in absorbing and reflecting 
photons. The main objective of this work was to develop successful oil in water (o/w) nanoemulsion for improving the solubility of BEMT and its 
protective characteristics. 
Methods: Pseudo-ternary phase diagrams were constructed using labrafac PG and isopropyl myristate as oil phase, tween 80 as surfactant (S) and 
cremophor EL as cosurfactant (CoS) the ratio of S/CoS was determined according to highest percent of water incorporation to the system. Full 
factorial study design (24) using Design-Expert® software was adopted to study the effect of four independent variables namely: oil type, oil 
concentration, S/CoSmix (3:1) concentrations and BEMT concentration on the particle size and the in vitro release at 2 h (Q2h
Results: Formula (F14) was chosen as the optimum formula having an in vitro SPF of 16.08±0.39, lowest permeation of 140±0.06 μg/cm
) of the prepared 
nanoemulsion formulae. Two systems each of eight formulae were developed and evaluated through droplet size analysis, zeta potential 
measurement, refractive index, in vitro drug release and according to the desirability value two formulae (F6 and F14) were used for further 
evaluations including in vitro sun protection factor (SPF), ex-vivo deposition by tape stripping technique, permeation test and photostability study. 
2after six h 
and highest photostability (t90%
Conclusion: Despite the poor solubility of bemotrizinol, it could be enhanced by novel drug delivery systems with good SPF value while maintaining 
its photostability. 
 = 168.02) after 120 min. 
Keywords: Bemotrizinol, Nanoemulsion, In vitro SPF, Ex-vivo deposition, Tape stripping technique, Photostability 




Many of our leisure activities take place outdoors, yet sun exposure 
has a negative impact on our skin, the effect of sunlight accumulate 
over a lifetime increasing the risk of developing permanent damage 
and consequently leads to skin cancer [1]. Sunscreen products are 
cosmetic products formulated to protect the skin from the damaged 
effects of solar radiations such as skin aging and skin cancer [2, 3]. 
Sunscreens contain molecules or molecular complexes that can 
absorb, reflect, or scatter UV photons, in order to prevent, 
ameliorate, or even repair solar-induced skin damage, they can be 
classified according to their mode of action into: systemic and 
topical sunscreens. The latter have two types; inorganic or physical 
agents which show UV reflection, scattering and in some cases 
absorption e. g., titanium dioxide and zinc oxide [4] while organic or 
chemical agents which absorb high energy UV rays can be classified 
according to their UV spectrum into UVA absorbers, UVB absorbers 
and UVA+UVB absorbers (broad spectrum) e. g., bemotrizinol and 
bisoctrizole. Ideal sunscreen should be able to provide high 
protection effect to skin from harmful effect of UV rays and should 
be formulated in a cosmetically acceptable form [5].  
Bemotrizinol is named as tinosorb S, anisotriazine or Bis-
ethylhexyloxyphenol methoxyphenyl triazene “BEMT” [6] and is 
considered as a hydrophobic sunscreening agent with high 
molecular weight (>500 g/mol), broad spectrum sunscreen filter 
(280-380 nm) that does not penetrate the skin, because of its 
relatively large size mwt 627.8 g/mol. BEMT has fewer side effects 
and it rarely causes allergic contact dermatitis, systemic absorption, 
or endocrine-like effects and decreased skin permeability [7]. 
Nanoemulsion is thermodynamically stable transparent or translucent 
system of two immiscible liquids stabilized by an interfacial film of 
surfactant and co-surfactant with a droplet size less than 100 nm [8] 
and can be classified into three types: oil in water nanoemulsions 
(o/w) for lipophilic drug encapsulation, water in oil nanoemulsions 
(w/o) for hydrophilic drug encapsulation and bi-continuous 
nanoemulsions [9]. The advantages of loading bemotrizinol in o/w 
nanoemulsion includes: a very small size of the nanoemulsion droplets 
which prevents any flocculation, creaming and sedimentation which 
might happens during storage; a good wettability, fluidity and 
spreadability; a transparent nature which gives a pleasant aesthetic 
character; the reduction in the trans-epidermal water loss due to its 
ability to strengthen the barrier function of the skin finally the high 
lipophilic nature of bemotrizinol makes it an excellent candidate to be 
loaded into nanoemulsion system. 
The aim of this study was to improve the solubility of bemotrizinol 
in a nanoemulsion cosmetic gel vehicle in order to improve its 
sunscreen efficacy adopting a simple production technique, in 
addition to the production of non-greasy formulae with low skin 
permeation. 
MATERIALS AND METHODS 
Materials  
Bemotrizinol (BEMT); cremophor EL (crem EL) and cremophor RH 40 
(crem RH40) were kindly donated as a gift from (BASF, Germany); 
wheat germ, rose and argan oil (All of analytical grade and used 
without further purification); labrafac PG, capryol 90, lauroglycol 90 
and labrasol were given as a gift from (Gattefossé, Saint Priest, 
France); isopropyl myristate (IPM), tween 80, 40 and 20 was 
purchased from (Sigma Aldrich, Germany); ethanol and methylene 
chloride (HPLC grade); potassium dihydrogen phosphate, disodium 
hydrogen phosphate, sodium chloride, magnesium sulphate and 
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calcium chloride (El-Nasr pharmaceutical Chemical Company, Cairo, 
Egypt); cellulose membrane with mwt cut off 12 000 Daltons (Sigma-
Aldrich, USA); double distilled water; helioscreen plates (North Sutton, 
NH, USA); newborn rat skin (animal house of Cairo University, Egypt). 
Methods 
Preformulation studies 
Saturated solubility of bemotrizinol in different vehicles 
Bemotrizinol solubility was determined in various oils (IPM, labrafac 
PG, capryol 90, lauroglycol 90, wheat germ oil, rose oil and argan oil), 
various surfactants (tween 80, 40 and 20) as well as various 
cosurfactants (crem EL and crem RH 40). An excess amount of BEMT 
was allowed to dissolve in 3 ml vehicle in 10 ml capacity stoppered 
vials separately. The mixtures were vortexed to facilitate solubilization 
using vortex mixer (stuart, UK). The mixture vials were kept at 37 
°C±1.0 in an isothermal shaker for 72 h to reach equilibrium. The 
mixtures were removed from the shaker and centrifuged for 30 min at 
2500 rpm to remove undissolved BEMT. The supernatants were 
filtered through a 0.45 μm millipore filter and the drug concentration 
in the filtrate was determined using a UV spectrophotometer (UV-
1601 PC, Shimadzu, Kyoto, Japan) at λmax 340 nm after appropriate 
dilution with either methylene chloride in case of the oily phase or 
ethanol in case of surfactants and cosurfactants [10]. 
Screening for S/CoS ratio using percentage of water 
incorporation method 
The ratios of surfactant to co-surfactants were chosen to be 1:0, 1:1, 
2:1, and 3:1. These mixtures (S/CoS) were mixed with the oil phase 
to give the weight ratios of 50:50, water was added drop by drop 
and stirred using a magnetic stirrer until a homogeneous dispersion 
or solution was obtained. After each addition, the system was 
examined for the appearance and flow properties. The end point of 
the titration was the point where the solution becomes cloudy or 
turbid. The quantity of the aqueous phase required to make the 
mixture turbid was noted. The percentages of the different 
incorporated phases were then calculated. The same procedure was 
followed for the other S/CoS ratios [11]. 
Construction of nanoemulsion pseudo-ternary phase diagrams 
A combination of S and CoS were prepared in the form of mixture 
with fixed ratio S/CoSmix 3:1 w/w according to the result of % water 
incorporation method and it was used as one component of the 
pseudo-ternary phase diagram in addition to water and oil phases. 
Phase diagrams were constructed by mixing oil, S/CoSmix
Factorial experimental design of the study 
 and water 
at certain weight ratios into glass vials, the mixtures in the vials 
were mixed using vortex (stuart, UK) for 2-3 min then incubated at 
room temperature for 72 h till equilibrium. After equilibrium, the 
mixtures were assessed visually as NEs [12]. All these points were 
marked in the phase diagrams and the area covered by these points 
was considered as the NE region of existence. 
Mixed levels full factorial experimental design (24) were carried out 
in order to investigate the influence of formulation variables on 
nanoemulsion properties using Design-Expert® software. The design 
was set at four independent variables: oil type, oil, S/CoSmix
Preparation of bemotrizinol loaded nanoemulsion formulae 
 and 
drug concentration. The measured responses (dependent variables) 
were particle size and two hours in vitro release (Q2h). 
In order to prepare the drug loaded NEs, the appropriate oil, 
S/CoSmix
Thermodynamic stability of bemotrizinol nanoemulsion formulae 
 weight ratios were weighed in glass vials, then 1% or 2% 
w/w of BEMT was accurately weighed and added to the mixture, 
vortexed and then water was added drop by drop at room 
temperature and vortexing was continued for 5 min, the resultant 
NEs were stored for 72 h at room temperature till equilibrium 
reached before further investigations [13]. 
The susceptibility of 1% and 2% w/w BEMT loaded nanoemulsions for 
metastable formulation were evaluated through the thermodynamic 
stability tests. The formulae were firstly centrifuged at 3500 rpm for 
30 min. The formulae that didn’t show any phase separations were 
subjected to heating-cooling cycle test. Three complete cycles, each 
cycle consisting of 24 h at 5°C followed by 24 h at 45 °C. Formulae that 
passed these circumstances and showed good stability were 
subsequently subjected to three freeze-thaw cycles test, each cycle 
consisting of 24 h at 25 °C followed by 24 h at-5 °C [12]. 
Pharmaceutical evaluation for the different prepared 
bemotrizinol nanoemulsion formulae 
Visual inspection 
The prepared formulae were examined for color, optical clarity, 
fluidity, homogeneity and phase separation (syneresis). 
Drug content determination 
The test was carried out by dissolving known quantity (0.1 g) of 
prepared BEMT nanoemulsion in 100 ml volumetric flask containing 
solvent (1% tween 80 sweat simulated (SSW) solution [14] 
(pH=5.5). This solution was left for 15 min with continuous stirring 
using a magnetic stirrer to ensure the drug was completely 
dissolved. The absorbance of this solution was measured by using 
UV spectrophotometer (UV-1601 PC, Shimadzu, Kyoto, Japan) at the 
predetermined λmax
pH measurement 
 of BEMT and the percentage of drug content in 
each NE was calculated. 
The pH of 10% w/w NE loaded drug in aqueous solution was 
measured by pH meter (HANNA instrument, USA). Solutions were 
prepared by dissolving 1 g of each NE formula in 9 g of double 
distilled water using magnetic stirrer. The pH meter was calibrated 
before each use with buffer solution of pH 4.0, 7.0 and 10 [10]. 
Test of spreadability 
Spreadability plays an important role in the patient compliance and 
help in uniform application of NE formulae to the skin. It mainly 
depends on the viscosity of the NE formulae, an increase in viscosity 
leads to decrease in spreadability. A sample of 0.5 g of each formula 
was placed between two slides of glass plates and left for about 5 
min where no more spreading was expected by the help of known 
weight (1 kg), after that the diameter of speadability of the NE was 
measured [15]. 
Refractive index (η) 
Each NE system was measured by Abbe refractometer (WAG-25, 
Shanghahai, China) by placing one part of the formulation on the 
slide in triplicate at 25 °C [16, 17]. The refractive index of a medium 
measures the extent of interaction between electromagnetic 
radiation and the medium through which it passes. 
Particle size and size distribution analysis 
The average droplet size and polydispersity index (PDI) of the 
prepared nanoemulsions were determined using Malvern Zetasizer 
(Malvern, UK). 0.1 g of each formula was dispersed into 10 ml of 
distilled water with gentle stirring. An aliquot of diluted 
nanoemulsion was transferred into the cell sample holder for 
droplets size analysis [18]. 
Determination of zeta potential 
Zeta potential was measured using Malvern Zetasizer (Malvern, UK). 
The diluted nanoemulsions with distilled water at ratio 1: 100 were 
exposed to an electric field (1v). 
Non-birefringence examination under cross-polarized microscope 
Bemotrizinol NE formulae were subjected to examination under 
cross-polarized microscope to test the absence of birefringence to 
exclude the presence of liquid crystalline systems [19]. A small 
quantity of the sample was placed on a clean glass slide and 
examined under cross-polarized microscope (Olympus, Japan). 
Rheological properties and viscosity measurements 
The viscosity of the prepared NE formulae was determined using 
(Brookfield DV III cone and plate Viscometer, ultra programmable 
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rheometer, USA) using spindle 52 at 25 °Ϲ. A certain weight of each 
formula 0.5 g was placed in the plate of the viscometer. The rpm was 
increased gradually in a suitable range to give torque values 
between 10-100 units within 15 s between each successive speed. 
In vitro-release studies of bemotrizinol nanoemulsion formulae 
In vitro release study of BEMT nanoemulsion formulae and coarse 
BEMT powder as control [20] were performed using a USP 
dissolution apparatus II (Hanson research, USA) with slight 
modification in 300 ml sweat simulated solution (pH=5.5) 
containing 1% tween 80 to maintain the sink condition [10] kept at 
37±0.5 °Ϲ. The stirring rate was 100 rpm. 2 mg/cm2 of each 
prepared NE formulae and coarse powder were placed in semi-
permeable membrane (cellulose nitrate pore size 0.45 µm) which is 
tight carefully from both sides and was hanged to the shaft of 
dissolution apparatus from both sides and dipped into the bottom of 
dissolution vessel. Every 60 min for 6 h, 5 ml samples were 
withdrawn and replaced with equal volume of fresh medium to 
maintain a constant volume. Analysis of samples was done for their 
BEMT content using UV spectrophotometer (UV-1601 PC, Shimadzu, 
Kyoto, Japan) at the predetermined λmax
Pharmaceutical evaluation of the selected BEMT nanoemulsion 
formulae 
, the mean percentage of 
BEMT released across the membrane was plotted as a function of 
time, all experiments were run in triplicates and the results were 
expressed as the mean average values±SD. 
Based on the highest in vitro release, the smallest particle size and 
the highest desirability values obtained from Design-Expert®
In vitro measurement of sun protection factor 
 
software, the selected BEMT nanoemulsion formulae (F6 and F14) 
were subjected to further investigation. 
The measurement of SPF value for each formula were done and 
calculated using a Labsphere UV 1000S ultraviolet transmittance 
analyzer (Labsphere, Inc., North Sutton, NH USA) at wavelength 
range 290-400 nm [21] through a sample placed on a helioscreen 
plate with the selected formula. Weigh and apply 2 mg/cm2
Water resistant test 
 of 
selected NE formulae over the helioscreen plates which possess 
topography parameters totally in compliance with ISO 24443 
method–Annex D method and to the Colipa rev. 2011 method. The 
application of each formula was done by the aid of micropipette and 
rubs it with a single finger-cot-coated then put the plate aside to dry 
for at least 20 min before measurements begin. At least three 
samples were prepared for each formula. 
The water-resistance component of the SPF test consists of 
alternating fresh water-immersion and drying procedures. The test 
was done by the sunscreen application then, the helioscreen plates 
were immersed in a shaking water bath containing 5 l fresh water 
used to prevent a high concentration of dispersed sunscreen and 
possible re-adsorption at 23-32 °C [22, 23] beside moderate activity 
in water done by adjusting it at 30 rpm, each followed by a 20 min 
rest/air dry period until the total water exposure time was reached. 
The test areas were air dried without toweling at the end of the last 
water-immersion period. The SPF values were measured before and 
after each immersion cycle which presents the protection retained 
after each water immersion [24]. A product will be claimed to be 
‘water resistant if its %WRR is>50%, and ‘very water resistant’ or 
‘waterproof’ if its %WRR is>80% after two 20 min immersions in 
water. 
HPLC method for detection and quantification of bemotrizinol 
An isocratic reversed phase (RP) validated HPLC method [25] with 
slight modifications followed by validation for these modifications 
was used for detection and quantification of BEMT. The apparatus 
used for HPLC analysis was Agilant 1260 infinity LC system 
equipped with quaternary pump, an auto-sampler unit and UV 
detector. Nova-pak C18 (150 mm x 3.9 mm) column packed with a 4 
μm-size adsorbent as stationary phase. The mobile phase was 
composed of 100% ethanol and the flow rate was set at 1.5 ml/min. 
The detector was set at 340 nm and the injection volume was 20 μl 
at room temperature. The retention time of BEMT recorded under 
the previous conditions was about 2.5 min. The stock solution of 
BEMT 0.1 mg/ml was prepared by dissolving 10 mg of BEMT in 100 
ml ethanol. Validation of assay procedures was done regarding 
linearity, precision, LLOD and accuracy. 
Ex-vivo permeation and deposition of bemotrizinol NE 
Ex-vivo permeation test 
The full body skin of newborn rat (one week-hairless rat) was 
obtained from the animal house of Cairo University and the 
experimental protocol was ethically approved by the Animal Care 
Committee, Faculty of pharmacy, Helwan University No (3) for 
27/11/2016. The skin subcutaneous tissue was removed surgically 
if present and the dermis side was wiped with isopropyl alcohol to 
eradicate adhering fat. 2 mg/cm2
The concentration of BEMT was analysed by the developed and 
validated RP-HPLC method at 340 nm using (Agilent 1260 HPLC 
system, USA). The cumulative amounts of permeated BEMT through 
the skin per unit surface area were calculated and subsequently 
used for plotting the profiles of the drug permeation per unit time 
(t). The rate of drug permeation at steady state (drug flux) (J
 of the prepared NE formula was 
spread over the surface of the newborn rat skin which was held on a 
glass cylinder tube of 2.5 cm diameter and held together by 
waterproof plaster and equally spaced plastic clips. This assembly 
was placed at the bottom of the dissolution vessel containing 300 ml 
of 1% w/v tween 80 in phosphate buffer saline (PBS) solution (pH 
=7.4) [26]. The permeation test was carried out for six hours at 37±1 
°C. The stirring rate was adjusted at a speed of 100 rpm. Every 60 
min an aliquot of 5 ml of the medium was withdrawn and replaced 
with equal volume of fresh medium.  
SS) was 
presented by the slope of the linear portion of the plotted profiles, 
the permeability coefficient (Kp) was calculated by dividing the JSS 
with initial concentration of the drug (C0
Ex-vivo deposition and accumulation test (Tape stripping 
technique) 
) µg/ml [27]. 
Our experimental study was extended for investigating the 
possibility of drug accumulation beneath the skin layers [28] and 
that deposit in the surface of stratum cornum. After 6 h the skin 
surface was washed five times with distilled water and was dried 
using filter paper in order to remove excess drug. By the aid of 
pieces of adhesive tape, the skin was tape stripping 20 times, tape 
strips and skin specimens were placed each in ethanol followed by 
sonication in order to extract the deposited drug [29], after 3 d the 
samples of strips and skin were filtered with filter memberane of 
pore size 0.45 µm before injected into HPLC column using the 
developed and validated RP-HPLC method at 340 nm (Agilent 1260 
HPLC system, USA) to analyse the amount of BEMT accumulated into 
SC, epidermis and dermis. 
Photostability and photostability kinetic studies 
Two criteria were considered to evaluate the photostability of 
sunscreens; the first one is based on the area under curve index by 
the aid of HPLC analysis and the second one is the residual 
percentage of two protection factors [30, 31] both give a similar 
ranking of the sunscreens photostability [6, 32]. 
Area under curve index  
Photodegradation of optimum formulae (F6 and F14) were 
evaluated using (Agilent 1260 HPLC system, USA) in the form of 
AUC. Each sample of 2 mg/cm2 was weighed and placed on a 
helioscreen plates (4×4 cm). The sunscreen was distributed over the 
entire surface by slowly and deliberately rubbing the surface of the 
plate with a single finger-cot-coated. The samples were irradiated 
with UVA and UVB radiation of intensity 35.35 and 15.91 W/m2 at 
different time intervals 20, 40, 60, 80, 100, 120, 140, 160 and 180 
min while the control sample was kept in a dark place [33]. After 
exposure, each plate was transferred to a beaker and washed well 
with ethanol and subjected to sonication using (Sonicator, Crest 
ultrasonic Crop., New York, USA) to allow the complete extraction of 
Hashim et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 7, 47-56 
50 
the nanoemulsion from the surface of the plate, this was then 
transferred to a 100 ml volumetric flask, diluted with ethanol to 
adjust volume [34]. The area under the curve of each sample was 
compared to AUC of both formulae before irritation (at zero time) [6, 
33]. Each point was calculated using the following equation:  
AUCIndex = AUC after
AUC before
  ....... (1) 
Residual percentage of SPF 
SPF value after irradiation was compared to the in vitro SPF value 
before irradiation which was measured using Labsphere UV 1000S 
ultraviolet transmittance analyzer (Labsphere, Inc., North Sutton, NH 
USA). The percentage variation of SPF [31] can be calculated as follow:  
% SPF = In−vitro SPFafter
In−vitro SPFbefore
× 100 ...... (2) 
Photostability kinetics was carried out by fitting the data of 
percentage SPF remaining after each time interval to different 
models namely; zero-order and first-order. The t 90%, and half-live 
(t 50%) were donated as the time necessary to obtain a decrease of 10 and 
50% of the initial SPF. The correlation coefficients (r2) and 
photodegradation rate constant (K) were also calculated. A time period 
of 120 min of irradiation was used to distinguish between good and 
poor photostability, because of the recommendation that a 
sunscreen is applied every 2 h. This recommendation led us to 
classify the filters in two categories, those whose t 90% is higher than 
2 h (good photostability) and those whose t 90%
RESULTS AND DISSCUSSION 
 is lower than 2 h 
(poor photostability) [33]. 
Preformulation studies 
Screening of bemotrizinol in different vehicle 
Based on the solubility study outcomes, labrafac PG and isopropyl 
myristate were used as oil, tween 80 and cremophor EL as 
surfactant and co-surfactant respectively for construction of the 
pseudoternary phase diagrams exhibiting the significantly highest 
BEMT solubility (p>0.05) as shown in table 1. 
 
Table 1: Solubility of BEMT in different vehicles 




Labrafac PG  86.75±2.86  
Capryol 90  57.77±0.22 
Wheat germ  46.97±0.67  
Lauroglycol 90  36.39±1.20  
Rose oil  34.67±0.09  
Argan oil  21.46±0.01  
 
Surfactant 
Tween 80  42.89±0.02 
Tween 20  19.67±0.88  
Tween 40  17.09±0.15  
Co-surfactant Cremophore EL  11.52±0.39 
Cremophore RH 40  7.73±0.42 
Data are presented as mean average value±SD, n=3. 
 
Screening for S/CoS ratio by using percentage of water 
incorporation method 
The maximum water percentage incorporation (Wmax) of each ratio 
is presented in table 2 which showed that Wmax was remarkably 
high (P<0.05) in ratio 3:1 in both oils. The Wmax of S/CoS ratio was 
found in the following order 3:1˃2:1 ˃1:1 ˃1:0. Increasing the S/CoS 
ratio to 3:1 improved the micelle formation and increased the 
solubilizing capacity of the nanoemulsion, co-surfactant was 
inserted into the cavities between the surfactant molecules and 
consequently, increased the solubilizing capacity of the formed 
nanoemulsion to maximum value [35]. 
 
Table 2: Maximum water percentage incorporation of different S/CoSmix
S/CoS
 ratios 
mix Oil type  ratios Wmax% (w/w) 
Tween 80: Crem EL (1:0) IPM 18.44±0.065  
Labrafac PG 10.12±0.075 
Tween 80: Crem EL (1:1) IPM 21.80±0.055 
Labrafac PG 13.38±0.29 
Tween 80: Crem EL (2:1) IPM 23.07±0.11 
Labrafac PG 15.62±0.14 
Tween 80: Crem EL (3:1) IPM 26.97±0.2 
Labrafac PG 16.34±0.17 
Data are presented as mean average value±SD, n=3. 
 
Construction of nanoemulsion pseudo-ternary phase diagrams 
Six diagrams were developed for IPM and labrafac PG as oils, 
tween 80 as surfactant and crem EL as co-surfactant in fixed ratio 
(3:1) which exhibited the largest water incorporation percentage. 
Three diagrams were constructed for each oil; one diagram as 
blank base without drug, the other two diagrams one contains 1% 
BEMT and the second 2% BEMT for each oil (fig. 1 and fig. 2). 
These diagrams were drawn with the aid of Sigma plot software 
(version 13). 
Preparation of bemotrizinol loaded nanoemulsion formulae 
Eight formulae were prepared for each oil according to 24
 
 factorial 
design plan. The composition of different BEMT nanoemulsion 
formulae are given in table 3. 
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Fig. 1: Ternary phase diagram of IPM as oil 
 
 
Fig. 2: Ternary phase diagram of Labrafac PG as oil 
 
Table 3: Composition of the different prepared BEMT nanoemulsion formulae 
Composition (w/w %) F1 F2 F3 F4 F5 F6 F7 F8 
BEMT 1% 1% 1% 1% 2% 2 % 2% 2% 
Labrafac PG 20% 20% 35% 35% 20% 20% 35% 35% 
S/CoS 50% mix 60% 50% 60% 50% 60% 50% 60% 
Water To 100 g 
Composition (w/w %) F9 F10 F11 F12 F13 F14 F15 F16 
BEMT 1% 1% 1% 1% 2% 2% 2% 2% 
IPM 20% 20% 35% 35% 20% 20% 35% 35% 
S/CoS 50% mix 60% 50% 60% 50% 60% 50% 60% 
Water To 100 g 
 
Thermodynamic stability of bemotrizinol nanoemulsion 
formulae 
None of the NE formulae showed phase separation or change in 
physical appearance such as turbidity or creaming. These results 
indicate that all NE formulae showed a good physical stability. 
Pharmaceutical evaluation for the different prepared BEMT 
nanoemulsion formulae 
Visual inspection 
The prepared BEMT NEs showed yellowish clear homogeneous 
systems with gel consistency and no phase separation. 
Drug content determination 
The percentage drug content of NE formulae ranged from 
98.85±0.32% to 107.4±0.2 % as in table 4. These results showed that 
the drug was uniformly distributed throughout the formulation and 
drug loss was low, these results indicated that the method of 
preparation was effective and of good capability to be loaded with 
BEMT up to 2% w/w. 
pH measurement 
The pH of the prepared formulae was found to mimic the skin pH 
(5.5-7) [36] as shown in table 4. 
Test of spreadability 
The spreadability values of all formulae were found to be in the 
range of 4.9±0.08 to 11.75±0.2 cm as shown in table 4. 
Refractive index 
The mean values of the refractive index of the nanoemulsion 
formulae were found in the range of 1.3682 to 1.4604 which is a 
good indication that all prepared NEs formulae are transparent and 
optically isotopic [37] as shown in table 4. 
Particle size and size distribution analysis  
The nanoemulsion average droplets were in size<100 nm as shown in 
table 5 where the small size of the droplets might be attributed to the 
penetration of co-surfactant molecules into the surfactant film and its 
ability to reduce the surface viscosity, fluidity and droplet radius of 
curvature [38]. It seems that the mean particle size was decreased 
with less percentage of oil phase and high percentage of S/CoSmix
Examination under cross polarized microscope showed that all 
prepared nanoemulsion formulae appeared dark, indicating 
isotropic properties of all formulae [41]. 
 [39]. 
Upon increasing the drug loading an increase in particle size was 
observed [40]. The polydispersity index (PDI) values were lower than 
0.6 which indicate the uniformity of droplet size. 
Determination of zeta potential 
The zeta potential of all nanoemulsion formulae was found between-
12.37±0.35 mV to-24.75±0.15 mV as shown in table 5. The zeta 
potential is a function of the surface charge which developed when 
any material is placed in a liquid. The negative charge indicates a 
deflocculated system in which repulsive forces exceeded the 
attractive forces, thereby keeping the particles dispersed [18]. 
Non-birefringence examination under cross-polarized microscope 
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Table 4: Characterization of prepared nanoemulsion formulae 
Formulae code Drug content (%)  pH Spreadability (cm)  Refractive index 
F1  101.73%±0.15 6.68±0.05 5.70±0.08 1.367±0.000 
F2  107.40%±0.20 6.82±0.01 8.10±0.08 1.447±0.000 
F3  104.75%±0.05 6.99±0.00 7.60±0.08 1.452±0.000 
F4  104.46%±0.12 6.26±0.00 9.75±0.20 1.452±0.001 
F5  104.67%±0.64 6.84±0.01 5.90±0.08 1.426±0.000 
F6  102.75%±0.55 6.27±0.01 9.70±0.08 1.447±0.000 
F7  106.36%±0.33 6.88±0.00 11.75±0.20 1.449±0.000 
F8  106.80%±0.10 6.33±0.00 8.85±0.12 1.460±0.000 
F9  100.27%±0.18 6.01±0.01 7.20±0.04 1.428±0.000 
F10  106.25%±0.17 6.95±0.04 8.45±0.04 1.444±0.000 
F11  105.88%±0.41 5.71±0.01 8.95±0.04 1.447±0.000 
F12  102.77%±0.12 7.00±0.00 10.25±0.20 1.455±0.000 
F13  102.61%±0.33 7.00±0.01 4.90±0.08 1.431±0.000 
F14  101.40%±0.03 6.36±0.01 8.10±0.08 1.448±0.000 
F15  106.30%±0.29 6.94±0.06 8.40±0.08 1.445±0.000 
F16  98.85%±0.32 6.81±0.00 10.15±0.12 1.460±0.000 
Data are presented as mean average value±SD, n=3. 
 
Table 5: Droplet size, PDI and zeta potential of prepared nanoemulsion formulae 
Formula code Droplet size (nm) PDI Zeta potential (mV) 
F1 27.23±0.60 0.303±0.004 -15.60±0.30 
F2 18.83±0.30 0.192±0.001 -14.45±0.45 
F3 44.24±1.64 0.211±0.001 -12.35±0.35 
F4 31.41±0.83 0.162±0.002 -20.50±1.00 
F5 57.40±0.77 0.534±0.015 -20.75±0.75 
F6 41.00±10.00 0.322±0.01 -19.10±0.20 
F7 166.30±1.60 0.249±0.005 -15.65±0.25 
F8 62.90±0.73 0.454±0.002 -18.25±0.65 
F9 49.28±0.81 0.542±0.001 -24.45±0.25 
F10 24.16±0.99 0.362±0.004 -17.20±0.70 
F11 47.00±1.00 0.269±0.001 -18.70±0.30 
F12 35.11±1.31 0.223±0.002 -19.05±0.25 
F13 54.50±1.50 0.311±0.0035 -24.75±0.15 
F14 104.79±1.49 0.495±0.018 -20.60±0.50 
F15 127.73±1.76 0.284±0.005 -17.55±0.25 
F16 55.70±1.33 0.381±0.004 -20.15±0.15 
Data are presented as mean average value±SD, n=3. 
 
Rheological properties and viscosity measurements 
BEMT NE formulae revealed non-newtonian, pseudo-plastic flow 
with thixotropy. The dermal dosage forms should exhibits 
comparatively high viscosity and plastic or thixotropic flow behavior 
to enable sticking onto the skin for a sufficient time [42]. 
In vitro release studies of bemotrizinol nanoemulsion formulae 
As the manufacturers suggest that the consumers should apply 
sunscreen products every two hours to maintain a constant amount 
of UV-filter on the skin surface. The release of drug at 2 h was 
considered as a measure for analysis. The higher % of drug released 
after 2 h was achieved by (F2, 6, 10 and 14) which might be 
attributed to their composition as they contain high concentration of 
S/CoSmix
 
 which allows the drug to be in a solubilized form and leads 
to small droplet size of their nanoemulsion making them excellent 
carrier for enhancing drug release. The lower % of drug released 
after 2 h was exhibited in (F1, 5, 9 and 13) might be attributed to 
their high viscosity which delay or hinder the release of the drug 
from the formulation as shown in (fig. 3 and fig. 4). 
 
Fig. 3: Release pattern of BEMT from different prepared nanoemulsion formulae using Labrafac PG 
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Fig. 4: Release pattern of BEMT from different prepared nanoemulsion formulae using IPM 
 
Statistical analysis of factorial design 
Effect of formulation variables on particle size analysis 
The concentration of oil used has a statistically significant effect on 
particle size. Akshay R. Koli reported that increasing oil 
concentration increase particle size. This could be explained by the 
fact that the higher the oil phase concentration, the more viscous is 
the nanoemulsion since higher oil concentration increase the 
interfacial tension between the aqueous phase and oil phase. 
Increasing S/CoSmix
Effect of formulation variables on 2h in vitro release 
 concentration in nanoemulsion yields 
decreasing in droplet particle size due to increase the adsorption 
around the oil-water droplet interface and decreased interfacial 
tension in the system leading to form nanoemulsion with smaller 
droplets [8]. Increasing the drug concentration in nanoemulsion 
system leads to increasing the particle size as shown in (fig. 5) 
where the nanosize of NE droplets was affected with the 
incorporation of the drug. However, it remained within the NE 
range, the increase in droplet diameter is due to the embedding of 
the drug in the interfacial layer of surfactants, which might decrease 
the curvature of the micelle and thus change the size of the droplets 
[43]. The 3D surface plots of each couple of the three numeric 
factors are illustrated in (fig. 5). 
Lower oil concentration resulted in higher % BEMT released from 
nanoemulsion formulae. As oil concentration increased, bigger 
droplets were formed with larger mean particle size and hence a 
lower in the amount of drug released [44], this might be also 
attributed to the high affinity of drug to the vehicle [45]. The % 
BEMT released from nanoemulsion formulae is higher in the 
presence of higher concentration of S/CoSmix
 
, this could be explained 
by the fact that small droplet size coupled with low interfacial 
tension [46]. Increasing the concentration of drug in drug loaded 
nanoemulsion leading to decrease in drug release across dialysis 
membrane, this is due to high concentration of drug leading to larger 
particle size so decrease in interfacial surface area for release of 
drug. The 3D surface plots of each couple of the three numeric 
factors are illustrated in (fig. 5). 
 
Fig. 5: Three dimensions surface plots for, a-The effect of oil concentration and S/CoS concentration on particle size, b-The effect of oil 
concentration and drug concentration on particle size, c-The effect of S/CoS concentration and drug concentration on particle size, d-The 
effect of oil concentration and S/CoS concentration on % BEMT released after 2 h, e-The effect of oil concentration and drug concentration 
on % BEMT released after 2 h, f-The effect of S/CoS concentration and drug concentration on % BEMT released after 2 h 
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Evaluation tests of the selected BEMT nanoemulsion formulae 
Based on the desirability value determined by Design-Expert®
The ex-vivo permeation parameters of F6 and F14 were illustrated 
in table 6. Upon comparing the permeation outcomes of the two 
selected NE formulae, a non-significant difference (p>0.05) 
between them was found and they could considered as safe 
formulae since the maximum skin penetration in organic filters is 
up to 5% [47]. This low permeation result could be explained 
considering the high ‘‘substantivity’’ of bemotrizinol towards 
keratin, intended as the ability of a substance to be adsorbed or 
absorbed by keratin substrates of epidermis, thus resulting in a 
minimization of its percutaneous absorption [48], in addition to its 
high molecular weight [49] and high solubility in labrafac PG oil 
and IPM oil. Since the vehicle could increase the solubility of the 
drug, then it would be retained in it after application on the 
surface of skin, resulting in a reduced skin penetration [45]. After 
the end of permeation experiment, the efficacy of the 
nanoemulsion formulae to penetrate through the skin layers was 
determined [29, 49]. The deposited and accumulated amount in 
newborn rat skin after exposing to BEMT nanoemulsion formulae 
were presented in table 7. It was found that BEMT nanoemulsion 
formulae showed higher drug deposited in stratum cornum than 
that accumulated in epidermis and dermis. This high amount 
might be attributed to the components of both nanoemulsion 
formulae which could interact with the lipid bilayers of the 
stratum corneum, thus enhancing drug deposition [50]. 
 
software, two nanoemulsion formulae were selected (F6 and F14 
respectively) with desirability factor (0.805, 0.775) respectively. 
In vitro measurement of sun protection factor  
The formula containing IPM as oil (F14 SPF = 16.08±0.39) showed 
noteworthy increase (***p<0.0001) than that contained labrafac PG (F6 
SPF = 10.30±0.12). This might be due to higher solubility of the drug in 
the NE vehicle containing IPM rather than that containing labrafac PG. 
Water resistant test  
Results of the in vitro water resistant testing of the optimum BEMT 
NE formulae (F6 and F14) after 40 and 80 min water immersion 
were found to be the same and considered to be non-water resistant 
formulae as they were completely washed out from the helioscreen 
plates during the first 40 min.  
Ex-vivo permeation and deposition of BEMT NE formulae (Tape 
stripping technique) 
 
Table 6: Permeation parameters of the selected BEMT nanoemulsion formulae after 6 h 
Formula r Flux (J2 SS) (µg/cm2 Kp (cm/h) /h) t50% Amount permeated (µg/cm (h) 2 Permeated % ) 
F6 0.95 25.28 0.541 24.42 142.64 5.03 
F14 0.88 28.96 0.620 21.87 140.31 4.92 
 
Table 7: Ex-vivo deposition and accumulation data of selected BEMT nanoemulsion formulae 
Formula 
code 
Amount of BEMT deposited in 
stratum cornum per unit area 
(µg/cm2
Amount of BEMT accumulated in 
epidermis and dermis per unit area 
(µg/cm)±SD 2




epidermis and dermis 
F6 681.902±26.54 86.04±0.929 23.91% 3.017% 
F14 643.034±43.39 151.86±4.197 22.55% 5.32% 
Data are presented as mean average value±SD, n=3. 
 
Photostability and photostability kinetic studies 
The results of area under curve index and residual percentage of 
SPFs gave a nearby finding of the sunscreens photostability [31, 33] 
after UV-light exposure at different time intervals as illustrated in 
table 8. Sunscreen was considered photostable when the percentage 
of SPF remained at least 80%. A time period of 120 min of 
irradiation was used to distinguish between good and poor 
photostability [31, 34]. From our findings the % SPF remained after 
120 min for F6 and F14 were 84.82% and 91.42% respectively, 
which means that the two selected nanoemulsion formulae 
possessed a good photostability. 
 
Table 8: % Recovery and % SPF remained of selected BEMT nanoemulsion formulae at different time interval 
Time (min) % Recovery of BEMT±SD % SPF remained±SD 
F6 F14 F6 F14 
0 100.00±0.20 100.00±0.07 100.00±0.45 100.00±0.59 
20 96.89±0.20 97.05±0.07 95.97±0.77 97.04±0.16 
40 93.83±0.27 93.20±0.04 91.50±0.84 95.12±0.81 
60 91.53±0.46 91.93±0.00 89.50±1.11 94.82±0.22 
80 87.35±0.02 91.67±0.03 85.34±0.38 93.20±0.49 
100 85.23±0.16 91.550.026 85.32±0.28 93.05±0.42 
120 85.06±0.13 90.64±0.01 84.82±0.62 91.42±0.27 
140 83.88±0.12 85.72±0.04 82.06±0.28 90.34±0.48 
160 82.19±0.06 83.33±0.03 80.05±0.12 90.09±0.48 
180 80.53±0.12 80.18±0.33 77.67±0.17 87.72±0.22 
Data are presented as mean average value±SD, n=3. 
 
The gradual decrease in SPF during photodegradation of BEMT in 
the selected nanoemulsion formulae was expressed by its 
degradation rate constant (K) which was calculated from the slope 
of the line of SPF versus time, t 90%, t 50% and correlation coefficient 
(r2) could be derived from kinetic analysis of the data as illustrated 
in table 9. According to the sunscreen stability testing, a product 
could be considered stable if it could preserve 80% of its 
effectiveness. In the event of exposure, it is recommended to the 
users to apply a sunscreen every two h. This recommendation led us 
to classify the filters in two categories, those whose t 90% is higher 
than two h (good photostability) and those whose t90% is lower than 
two h (poor photostability) [51]. 
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Table 9: Kinetic parameters outcomes of photostability of BEMT from F6 and F14 nanoemulsion formulae 
Formula code Zero-order First-order Order of degradation 
R K 2 T T90% R50% K 2 T T90% 50% 
F6 0.949 0.11 83.72 418.60 0.960 0.0006 81.75 537.80 First-order 
F14 0.958 0.05 165.67 828.36 0.962 0.962 168.02 1105.41 First-order 
 
The t 90% was found to be equal to 81.75 and 168.02 min for F6 and 
F14 respectively which indicated that the optimum BEMT 
nanoemulsion formula was F14 where its t90% 
CONCLUSION 
is higher than two h 
when compared to F6. The high photostability of bemotrizinol was 
reckoned on its molecular structure that facilitates the dissipation of 
incident energy by intramolecular heat transfer and vibrational 
relaxation; therefore, no reactive intermediate species and no 
photolytic decomposition products were formed in the skin [52]. 
The developed bemotrizinol nanoemulsion showed good 
characterization in terms of rheological behavior making it suitable 
for skin application. The transparent non-gritty appearance of the 
prepared nanoemulsion confirmed the homogeneity dispersion of 
the drug in the system with improved filter efficacy by the aid of a 
single sunscreening agent, decreased permeation and enhanced 
photostability emphasize the potential use of nanoemulsions as 
cosmetic bases for lipophilic chemical sunscreening bemotrizinol. 
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